TORONTO (AP) — A person familiar with the matter says Canada’s National Advisory Committee on Immunization is recommending a pause on AstraZeneca COVID-19 vaccinations for people under 55 for safety reasons. The person confirmed the recommendation on condition on anonymity as they were not authorized to speak publicly before the announcement. It is a recommendation and it is up to each of Canada’s provinces to decide to follow it or not. It was not immediately clear why that is being recommended in Canada. But several European countries that had suspended using the vaccine over concerns it could cause blood clots have resumed administering it.
Photo courtesy of Miguel Medina / AFP - Getty Images
A person familiar with the matter says Canada’s National Advisory Committee on Immunization is recommending a pause on AstraZeneca COVID-19 vaccinations for people under 55 for safety reasons.
Posted: Mar 29, 2021 12:56 PM
Updated: Mar 29, 2021 12:57 PM
- Canadian Panel Recommends AstraZeneca Pause for People Under 55
- US recommends 'pause' for J&J vaccine over clot reports
- AstraZeneca's Covid-19 Vaccine Approved in the U.K.
- AstraZeneca vaccine being tweaked to fight S. Africa variant
- Oxford-AstraZeneca Covid-19 vaccine is safe, European Medicines Agency rules
- AstraZeneca: US data shows vaccine effective for all ages
- FDA Advisory Panel Votes to Recommend Emergency use of Pfizer Vaccine, Probably Leading to Final Approval this Week
- CDC advisory panel recommends use of Pfizer vaccine for Kids 12 to 15, Clearing Hurdle for Millions of More Shots
- AstraZeneca vaccine appears to substantially reduce transmission of the coronavirus, study shows
- Ireland halts use of AstraZeneca vaccine following blood clot reports in Norway
Scroll for more content...